Patricia U. M.
- Country
- Spain
- Department
- Ophtalmology
Research Overview
- Evaluation of Ranibizumab Port Delivery System Refill Regimens in Neovascular Age-Related Macular Degeneration: A Phase IIIb Randomized Study
- Evaluation of Elamipretide Subcutaneous Injections in Patients with Dry Age-Related Macular Degeneration: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Trial
- Evaluation of Suprachoroidal Dexamethasone Acetate (OXU-001) Versus Intravitreal Dexamethasone Implant in Diabetic Macular Edema
Data & Insights
Has run more than one trial at 38 of 106 partner sites.
Specializations
Retinal Disease Management
The investigator specializes in treating various forms of age-related macular degeneration (AMD), including both wet and dry variants. Their expertise extends to innovative delivery systems and therapeutic approaches for managing retinal conditions.
- Neovascular AMD Treatment
- Geographic Atrophy Management
- Port Delivery System Applications
Particular focus is placed on long-term treatment strategies and novel drug delivery methods for retinal disorders.
Diabetic Eye Care
Expertise in managing diabetic macular edema (DME), with specific interest in suprachoroidal delivery methods and advanced therapeutic interventions for diabetic eye complications.
- Diabetic Macular Edema Treatment
- Suprachoroidal Drug Delivery
- Novel Therapeutic Approaches
The investigator explores innovative treatment modalities for diabetic eye disease management.
Advanced Drug Delivery Systems
Focus on developing and implementing innovative drug delivery platforms for ophthalmic conditions, including sustained-release devices and alternative administration routes.
- Port Delivery System Development
- Subcutaneous Administration Methods
- Extended-Release Treatments
Emphasis on improving treatment efficiency through advanced delivery mechanisms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.